RIO DE JANEIRO, BRAZIL - The head of the research group that eliminated the virus from the "São Paulo patient" reports that the new phase of studies is expected to begin at the end of the year.
The researcher and infectiologist at the Federal University of São Paulo (Unifesp), Ricardo Sophie Diaz, intends to begin the new phase of clinical trials with the treatment that eliminated HIV that causes AIDS in a resident of São Paulo.
In this new phase, the team led by Diaz will increase the number of participants in the clinical trial to 70, with . . .